calcipotriene

Also found in: Medical.

Related to calcipotriene: Calcitriol, Tazarotene, Calcipotriol

Translations

calcipotriene

n calcipotrieno

References in periodicals archive ?

Release date- 07082019 - Copenhagen - MC2 Therapeutics A/S, a late clinical-stage pharmaceutical company focused on topical therapies for chronic inflammatory conditions, today announced the completion of enrollment for its EU Phase 3 study assessing the safety and efficacy of MC2-01 PAD Cream (calcipotriene and betamethasone dipropionate, w/w 0.005%/0.064%) in adult patients with plaque psoriasis compared to Daivobet gel (marketed in the US as Taclonex Topical Suspension).

MC2 Therapeutics A/S Completes Enrollment of EU Phase 3 Head-to-Head Study in Patients with Plaque Psoriasis Treated with MC2-01 PADTM Cream

- The US Food and Drug Administration has expanded the approved indication for Enstilar (calcipotriene and betamethasone dipropionate) Foam, 0.005%/0.064%, for the topical treatment of plaque psoriasis to include patients age 12 and older, US-based medical dermatology company Leo Pharma Inc., a wholly owned subsidiary of Denmark-based Leo Pharma A/S, said.

Leo Pharma Wins US Food and Drug Administration Expanded Regulatory Approvals for Enstilar Foam and Taclonex Topical Suspension in Treatment of Plaque Psoriasis

Yet another example of changing the vehicle to improve efficacy can be seen with the fixed-dose combination of calcipotriene and betamethasone dipropionate.

Topical Therapies for Psoriasis: The Revolution in Vehicles, Combinations, and Novel Agents

M2 EQUITYBITES-May 23, 2019-US Food and Drug Administration approves Mayne Pharma Group's SORILUX (calcipotriene) Foam

US Food and Drug Administration approves Mayne Pharma Group's SORILUX (calcipotriene) Foam

Pharmaceutical company Mayne Pharma Group Limited (ASX:MYX) reported on Wednesday the receipt of approval from the US Food and Drug Administration (FDA) for SORILUX (calcipotriene) Foam, 0.005%, for treating plaque psoriasis of the scalp and body in patients aged 12 years and older.

Mayne Pharma awarded FDA approval for SORILUX for treating adolescent plaque psoriasis

Keywords: Betamethasone dipropionate, Calcipotriene, Vitiligo.

COMPARISON OF EFFICACY OF TOPICAL CALCIPOTRIENE PLUS BETAMETHASONE WITH CALCIPOTRIENE ALONE IN LOCALIZED VITILIGO

Localized plaques that do not restrict movement may be treated with topical corticosteroids, calcipotriene, and tacrolimus.

Morphea

In a randomised, double-blinded, controlled trial of Van der Vleuten CJ et al, [21] 71.2% of patients achieved "absent" or "very mild" disease with the two-compound scalp formulation, compared to 64% with betamethasone dipropionate and 36.8% with calcipotriene alone.

A comparative study of efficacy of hand foot psoralen-ultraviolet a therapy versus sequential therapy of topical clobetasol propionate with topical calcipotriol ointment in palmoplantar psoriasis

Vitamin D analogues such as Calcipotriene (Dovonex) slow down the growth of skin cells.

Psoriasis Treatment Market by Drug Classes, Therapies, Distribution Channel and Forecast to 2021, Upcoming Report by iHealthcareAnalyst, Inc.

Combined topical calcipotriene ointment 0.005% and various systemic therapies in the treatment of plaque-type psoriasis vulgaris: review of the literature and results of a survey sent to 100 dermatologists.

Evaluation of psoriasis severity and inflammatory responses under concomitant treatment with methotrexate plus micronutrients for psoriasis vulgaris: a randomized double blind trial

Since our patient's underlying CML necessitated continued treatment with dasatinib and he declined procedural treatments, we treated his dyschromia topically with mometasone 0.1% and calcipotriene 0.005% creams.

Development of Asymmetric Facial Depigmentation in a Patient Treated with Dasatinib with New-Onset Hypovitaminosis D: Case Report and Review of the Literature

Full browser ?

CITE

Site: Follow: Share:

Open / Close